American
association of clinical endocrinologists and American college of endocrinology published recently
clinical practice guidelines for comprehensive medical care of patients with
obesity! Take a look sleep apnea and asthma are included for obligatory screening!
Obstructive sleep apnea
• R21. All patients with overweight or obesity should be evaluated for obstructive sleep apnea during medical history and physical examination; this is based on the strong association of these disorders with each other (Grade B; BEL 2).
Polysomnography and other sleep studies, at home or in a sleep lab, should be considered for patients at high risk for sleep apnea based on clinical presentation, severity of excess adiposity, and symptomatology (Grade D). All patients with
obstructive sleep apnea should be evaluated for the presence of overweight or obesity (Grade B; BEL 2).
• R21. All patients with overweight or obesity should be evaluated for obstructive sleep apnea during medical history and physical examination; this is based on the strong association of these disorders with each other (Grade B; BEL 2).
Polysomnography and other sleep studies, at home or in a sleep lab, should be considered for patients at high risk for sleep apnea based on clinical presentation, severity of excess adiposity, and symptomatology (Grade D). All patients with
obstructive sleep apnea should be evaluated for the presence of overweight or obesity (Grade B; BEL 2).
Asthma/reactive airway disease
• R22. All patients with overweight or obesity should be evaluated for asthma and reactive airway disease based on the strong association of these disorders with each other (Grade B; BEL 2). Based on medical history, symptomatology, and
physical examination, spirometry and other pulmonary function tests should be considered for patients at high risk for asthma and reactive airway disease (Grade D). All patients with asthma should be evaluated for the presence of
overweight or obesity (Grade D).
• R22. All patients with overweight or obesity should be evaluated for asthma and reactive airway disease based on the strong association of these disorders with each other (Grade B; BEL 2). Based on medical history, symptomatology, and
physical examination, spirometry and other pulmonary function tests should be considered for patients at high risk for asthma and reactive airway disease (Grade D). All patients with asthma should be evaluated for the presence of
overweight or obesity (Grade D).
full text links:
Executive summary:
Algorithm
No comments:
Post a Comment